Wednesday, March 10, 2021 11:15:35 PM
FWIW
Emailed Janet Woodcock as well, and got the standard response, "can't comment..." . So, rather annoyed, sent another email asking her if she had actually read my message, to which she replied, she had.
Oh well, decided I wasn't getting very far with her, so sent off emails to two members of the House and also forwarded my Janet Woodcock letter as well. And finally, a Dr Offit from the children's Hospital of Philadelphia (appears to be a "heavy-hitter" in vaccines and infectious diseases). I listened to an interview with him on CNN this evening. I also sent him the same message and followed up with my woodcock letter. Hopefully, someone will recognize and act upon the import of Woodcock's, "No way an EUA."
Politically, Woodcock's position could give the Republicans a real hammer. Picture a headline, "Biden's choice of Janet Woodcock as commissioner of the FDA potentially sends thousands to their graves." Then the actual account of her refusal to allow Leronlimab to be used and thus lower the death toll by a minimum of 25%.
FWIW - anyone who is "older" should have a real concern with her decision. The vaccines are all very well and good, but will eventually lead to confusion.
"Has that person, 'masklessly' walking down the street, been vaccinated with active immunity, vaccinated with waning or expired immunity, or just a flaming sphincter? If we catch it, at an advanced age, the numbers are definitely against us and the current SOC is a poor choice without the addition of leronlimab. My wife and I have managed to survive one year, but with the potential for new raging variants coming at us, and bozos thinking it's their Constitutional right to infect everyone else...survival is very "iffy" (we reside in the suburbs of Phila. and the incidence is often in the "red zone").
Emailed Janet Woodcock as well, and got the standard response, "can't comment..." . So, rather annoyed, sent another email asking her if she had actually read my message, to which she replied, she had.
Oh well, decided I wasn't getting very far with her, so sent off emails to two members of the House and also forwarded my Janet Woodcock letter as well. And finally, a Dr Offit from the children's Hospital of Philadelphia (appears to be a "heavy-hitter" in vaccines and infectious diseases). I listened to an interview with him on CNN this evening. I also sent him the same message and followed up with my woodcock letter. Hopefully, someone will recognize and act upon the import of Woodcock's, "No way an EUA."
Politically, Woodcock's position could give the Republicans a real hammer. Picture a headline, "Biden's choice of Janet Woodcock as commissioner of the FDA potentially sends thousands to their graves." Then the actual account of her refusal to allow Leronlimab to be used and thus lower the death toll by a minimum of 25%.
FWIW - anyone who is "older" should have a real concern with her decision. The vaccines are all very well and good, but will eventually lead to confusion.
"Has that person, 'masklessly' walking down the street, been vaccinated with active immunity, vaccinated with waning or expired immunity, or just a flaming sphincter? If we catch it, at an advanced age, the numbers are definitely against us and the current SOC is a poor choice without the addition of leronlimab. My wife and I have managed to survive one year, but with the potential for new raging variants coming at us, and bozos thinking it's their Constitutional right to infect everyone else...survival is very "iffy" (we reside in the suburbs of Phila. and the incidence is often in the "red zone").
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
